FDA Center for Drug Evaluation & Research Issues Warning Letter to Dry Springs Pharmacy
April 15, 2026
April 15, 2026
WASHINGTON, April 15 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Dry Springs Pharmacy from its Center for Drug Evaluation and Research:
* * *
Recipient: Dry Springs Pharmacy, Hong Kong SAR China
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
MARCS-CMS 723460
Dry Springs Pharmacy:
This i . . .
* * *
Recipient: Dry Springs Pharmacy, Hong Kong SAR China
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
MARCS-CMS 723460
Dry Springs Pharmacy:
This i . . .
